Alaunos Therapeutics, Inc. Current Portion of Long-Term Debt
Alaunos Therapeutics, Inc. (TCRT) had Current Portion of Long-Term Debt of $0 as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current
us-gaap:LongTermDebtCurrent · last filed 2024-04-01
- 2023-12-31: Long-term Debt, Current Maturities $0.00.
- 2023-09-30: Long-term Debt, Current Maturities $0.00.
- 2023-06-30: Long-term Debt, Current Maturities $0.00.
- 2023-03-31: Long-term Debt, Current Maturities $10.99M.
| Period end | Long-term Debt, Current Maturities |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-04-01 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 |
| 2023-03-31 | $10.99M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $16.77M 10-K · filed 2024-04-01 |
| 2022-09-30 | $22.67M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $20.05M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $13.99M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $7.87M 10-K · filed 2023-03-07 |
| 2021-09-30 | $12.04M 10-Q · filed 2021-11-08 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |